🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to document the immunological response to the ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362336
Treatments Being Tested
To demonstrate that the immune response to hepatitis B antigen of the DTaP-...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00315055
Treatments Being Tested
The purpose of the study is to provide immunogenicity and safety data of th...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00401531
Primary Objective: * To demonstrate that the immune response of the DTaP-I...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00831311
Treatments Being Tested
To demonstrate that DTaP-IPV-HB-PRP\~T combined vaccine does not induce a h...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00313911
Treatments Being Tested
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
DTaP-HB-PRP\~T combined vaccine is being developed in order to comply with ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00514709
Treatments Being Tested
This study will assess both the antibody persistence of the investigational...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00303316
Treatments Being Tested
The purpose of this study is to support the registration of the pentavalent...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00343889
Treatments Being Tested
Primary objectives: To investigate the incidence of adverse events occurre...
Status
Completed
Location
Investigational Site Number : 002
Start Date
2025-01-17
Trial ID
NCT06793826
Treatments Being Tested